Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Pennsylvania Attorney General announces…

By Pharmaceutical Processing | June 2, 2004

HARRISBURG, PA (June 2, 2004) – Pennsylvania State Attorney General Jerry Pappert today announced that checks totaling more than $272,000 will be released to Pennsylvanians who submitted claims for purchases of the cancer-fighting drug Taxol or its generic equivalent Paclitaxel.

Pappert said the funds are part of an overall $62.5 million multi-state settlement with New York-based drug manufacturer Bristol-Myers Squibb, to resolve alleged antitrust, consumer protection and unfair competition laws. The national consumer reimbursement portion of the settlement was $12.5 million. The settlement also required reimbursement to state Medicaid and other programs that purchased the drugs, plus funds to the states for the treatment of lower income cancer patients.

In June 2002, Attorneys General from all 50 states and the U.S. Territories accused Bristol-Myers Squibb of manipulating the patent process to keep the cheaper, generic version of Taxol off the market. The states’ lawsuit claimed that BMS fraudulently obtained patents that would extend its monopoly on the drug.

“In Pennsylvania, the average consumer paid several hundred dollars more per treatment for these drugs than necessary,” Pappert said. “Our resolution to this case reimburses the victims and stops the drug company from engaging in a practice that overcharged the seriously ill.”

Nationally, 12,723 consumers will recover more than $7.2 million.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE